Skip to main content
Tessa NewsLink
Paste a health news link, or browse
Latest checks

Source study found

Story checked

Needle-free mRNA vaccines protect mice against COVID-19 and flu (opens in a new tab)

news-medical.net · 2026-10-22

Short answerEvidenceSource

Short answer

Mostly not supported

Mostly not supported.

The claims we could check match the study, but some claims were not covered by the evidence reviewed.

  • 1 supported
  • 4 not covered

Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.

Share this check

Follow the evidence trail
1
2

NewsLink checks it

Mostly not supported

The one claim we could check holds up. One of five claims matches the study. This overall rating is based only on the claims we could check. Four claims the study doesn't address.

  • 1 supported
  • 4 not covered
Open claim evidence
3
Then inspect each claim

Evidence layer

Claim by claim

Each claim gets a verdict. Expand it to see the evidence directly below.

5 claims in this story

Showing all 5 claimsChoose a verdict to focus the list.

Claim 1 of 5Not coveredThe Journal of Clinical Investigation study from researchers at Rutgers and Japanese institutions tested experimental improvements to mRNA vaccine delivery using a high-pressure liquid jet that delivers mRNA into the skin plus two substances that strengthen the immune response.View evidenceHide evidence

Why this verdict

The scientific setup is supported at abstract depth: the paper screened improvements to naked mRNA delivery by skin liquid jet-injection and identified aluminum phosphate + CpG as an effective adjuvant combination. However, the supplied abstract-level profile does not verify the Journal of Clinical Investigation venue, Rutgers/Japanese institutional affiliations, or the exact 'high-pressure' description.

1

Study evidence

A combination of aluminum phosphate and CpG oligonucleotide substantially enhanced both humoral and cellular immune responses and increased the IgG2a/IgG1 ratio when used with naked N1-methyl-pseudouridine–modified mRNA delivered by skin liquid jet-injection in mice.substantial enhancement (as described in abstract)

“we screened clinically relevant adjuvants to enhance the efficacy of N1-methyl-pseudouridine-modified naked mRNA jet-injection vaccines in mouse models”
Claim 2 of 5Not coveredCombining two adjuvants, aluminum phosphate and CpG, boosted both antibody and cellular responses, whereas adding the adjuvants individually offered little benefit and sometimes weakened parts of the response.View evidenceHide evidence

Why this verdict

The profile supports that the aluminum phosphate + CpG combination substantially enhanced humoral and cellular responses, and that many other adjuvants had little or inhibitory effects. But the abstract-level evidence does not specify that aluminum phosphate alone and CpG alone individually offered little benefit or weakened responses, so that more detailed comparison is not verifiable at this depth.

1

Study evidence

A combination of aluminum phosphate and CpG oligonucleotide substantially enhanced both humoral and cellular immune responses and increased the IgG2a/IgG1 ratio when used with naked N1-methyl-pseudouridine–modified mRNA delivered by skin liquid jet-injection in mice.substantial enhancement (as described in abstract)

“we screened clinically relevant adjuvants to enhance the efficacy of N1-methyl-pseudouridine-modified naked mRNA jet-injection vaccines in mouse models”
Claim 3 of 5Not coveredAfter three doses, infectious virus was below detection limits in lung samples from mice given the boosted vaccines and later exposed to SARS-CoV-2 or influenza A; in the COVID-19 experiment, lung viral RNA was about 24 times lower than after vaccination without the adjuvants.View evidenceHide evidence

As statedabout 24 times lower

Why this verdict

The abstract supports near-elimination of SARS-CoV-2 and influenza A infection in mice by plaque-forming assays. It does not provide the stated three-dose schedule, lung-sample source, below-detection-limit wording, viral RNA endpoint, or the quantitative claim that COVID-19 lung viral RNA was about 24-fold lower than vaccination without adjuvants.

1

Study evidence

Adjuvanted naked mRNA jet-injection vaccine (aluminum phosphate + CpG) virtually eliminated SARS-CoV-2 infection in challenged mice as measured by plaque-forming assays.Virtually eliminated infection (plaque-forming assay readout)

“virtually eliminated infection by ... SARS-CoV-2 ... in plaque-forming assays”
2

Study evidence

Adjuvanted naked mRNA jet-injection vaccine 'virtually eliminated infection' by influenza A (A/California/7/2009 H1N1) in mice as measured by plaque-forming assays.Qualitative: reported as 'virtually eliminated' detectable infectious virus (no numeric PFU values provided in abstract).

“virtually eliminated infection by ... influenza A virus (A/California/7/2009 H1N1) in plaque-forming assays”
Claim 4 of 5Not coveredSeparate experiments found less local and systemic inflammation than with laboratory lipid-particle formulations of mRNA vaccine, and the authors said the method still needs testing in larger animals before human trials.View evidenceHide evidence

Why this verdict

The profile supports lower local and systemic reactogenicity versus LNP-formulated mRNA in mice. But the abstract-level profile does not verify the story's author-attributed statement that larger-animal testing is required before human trials; it only establishes that the work is in mice and human generalizability is not addressed.

1

Study evidence

Adjuvanted naked mRNA (aluminum phosphate + CpG) induced IgG2a and cellular immune responses reported as comparable to those induced by LNP‑formulated mRNA in mice.

“This adjuvanted naked mRNA vaccine induced IgG2a and cellular immunity at levels comparable to those achieved with LNPs”
2

Study evidence

In mice, the adjuvanted naked mRNA jet-injection vaccine exhibited lower local and systemic reactogenicity than LNP-formulated mRNA, as reported in the abstract.

“but with lower local and systemic reactogenicity”
Claim 5 of 5SupportedA needle-free vaccination method protected mice against the viruses that cause COVID-19 and flu, offering a possible new way to deliver mRNA vaccines while limiting unwanted inflammation.View evidenceHide evidence

Why this verdict

The abstract-level profile supports that naked mRNA delivered by skin liquid jet-injection with aluminum phosphate + CpG protected mice against SARS-CoV-2 and influenza A in challenge experiments, and that the optimized formulation had lower local/systemic reactogenicity than LNP-formulated mRNA. The headline is hedged as a possible delivery approach and stays within mouse evidence.

1

Study evidence

A combination of aluminum phosphate and CpG oligonucleotide substantially enhanced both humoral and cellular immune responses and increased the IgG2a/IgG1 ratio when used with naked N1-methyl-pseudouridine–modified mRNA delivered by skin liquid jet-injection in mice.substantial enhancement (as described in abstract)

“we screened clinically relevant adjuvants to enhance the efficacy of N1-methyl-pseudouridine-modified naked mRNA jet-injection vaccines in mouse models”
2

Study evidence

In mice, the adjuvanted naked mRNA jet-injection vaccine exhibited lower local and systemic reactogenicity than LNP-formulated mRNA, as reported in the abstract.

“but with lower local and systemic reactogenicity”
Then look for missing context

Context layer

What the story left out

Important study details the story did not include.

  • The optimized adjuvanted naked mRNA formulation had immunogenicity comparable to LNP-formulated mRNA for IgG2a and cellular immunity in mice.

    The story emphasizes improved protection and lower inflammation/reactogenicity, but it does not clearly report the comparable-immunogenicity benchmark against LNP-mRNA.

    From comparative in vivo mouse immunization

  • Mechanistic investigations implicated type I interferon signaling during immunization.

    The story does not discuss the type I interferon mechanism.

    From in vivo mechanistic perturbation (abstract-level)

  • Mechanistic investigations implicated IL-6 signaling during immunization.

    The story does not discuss the IL-6 mechanism.

    From in vivo animal

7 things the story did carry across
  • The paper's central formulation result is a skin liquid jet-injected, naked N1-methyl-pseudouridine mRNA vaccine whose immunogenicity is boosted by the aluminum phosphate + CpG adjuvant combination.
  • The adjuvant combination enhanced both humoral and cellular immune responses in mice, with Th1-skewing/increased IgG2a/IgG1 ratio reported in the abstract.
  • Many other clinically relevant adjuvants had little or inhibitory effects in the screening context, but the abstract does not detail each individual adjuvant condition.
  • The optimized adjuvanted naked mRNA formulation had lower local and systemic reactogenicity than LNP-formulated mRNA in mice.
  • The vaccine formulation virtually eliminated SARS-CoV-2 infection in challenged mice as measured by plaque-forming assays.
  • The vaccine formulation virtually eliminated influenza A H1N1 infection in challenged mice as measured by plaque-forming assays.
  • A major limitation is that the evidence is from mouse experiments, with human generalizability not established in the abstract.
Then read the study layer

Study layer

Study at a glance

Scan the study first. Expand only the parts you want to inspect.

Pieces of work

7

Evidence read

study summary

Lead result

in vivo animal

1Lead resultin vivo animalScreen clinically relevant adjuvants and identify an effective combinational adjuvant (aluminum phosphate + CpG) that enhances immunogenicity of naked (non-LNP) N1-methyl-pseudouridine–modified mRNA delivered by skin liquid jet-injection in mice, including Th1-skewing (IgG2a/IgG1) and cellular responses.in vivo mouse adjuvant screen (skin liquid jet-injection)Expand

In plain English

In mice, a screen of clinically relevant adjuvants added to N1-methyl-pseudouridine–modified naked mRNA delivered by skin liquid jet-injection identified an aluminum phosphate + CpG oligonucleotide combination that substantially enhanced both humoral and cellular immune responses and increased the IgG2a/IgG1 ratio; many other tested adjuvants had little or inhibitory effects.

Key findings

  • A combination of aluminum phosphate and CpG oligonucleotide substantially enhanced both humoral and cellular immune responses and increased the IgG2a/IgG1 ratio when used with naked N1-methyl-pseudouridine–modified mRNA delivered by skin liquid jet-injection in mice.substantial enhancement (as described in abstract)
  • Many other clinically relevant adjuvants tested showed little or inhibitory effects on inducing humoral or cellular immunity in this naked mRNA jet-injection platform.little or inhibitory effect (as described in abstract)
“we screened clinically relevant adjuvants to enhance the efficacy of N1-methyl-pseudouridine-modified naked mRNA jet-injection vaccines in mouse models”
What this piece can’t prove
  • Abstract lacks methodological details (specific adjuvants tested beyond the highlighted combination, doses, schedules, sample sizes, and exact immunologic assays).

3 further details could not be confirmed from the summary.

2in vivo animalBenchmark the optimized adjuvanted naked mRNA jet-injection formulation against LNP-mRNA for immunogenicity and for local/systemic reactogenicity in mice.comparative in vivo mouse immunizationExpand

In plain English

In mice, a jet‑injected naked mRNA vaccine adjuvanted with aluminum phosphate plus CpG induced IgG2a and cellular immune responses reported as comparable to those elicited by LNP‑formulated mRNA, while producing lower local and systemic reactogenicity according to the abstract.

Key findings

  • Adjuvanted naked mRNA (aluminum phosphate + CpG) induced IgG2a and cellular immune responses reported as comparable to those induced by LNP‑formulated mRNA in mice.
  • The adjuvanted naked mRNA formulation produced lower local and systemic reactogenicity than LNP‑formulated mRNA (abstract statement).
“This adjuvanted naked mRNA vaccine induced IgG2a and cellular immunity at levels comparable to those achieved with LNPs”
What this piece can’t prove
  • Summary is based solely on the abstract; primary paper text, figures, and supplementary data (which likely contain quantitative results, sample sizes, and statistical analyses) were not available for this unit.

2 further details could not be confirmed from the summary.

3in vivo animalBenchmark the optimized adjuvanted naked mRNA jet-injection formulation against LNP-mRNA for immunogenicity and for local/systemic reactogenicity in mice.in vivo animalExpand

In plain English

The abstract reports that, in mice, an optimized formulation of aluminum phosphate + CpG–adjuvanted naked N1-methyl-pseudouridine–modified mRNA delivered by liquid jet injection had lower local and systemic reactogenicity than LNP-formulated mRNA while maintaining comparable immunogenicity. Specific reactogenicity measurements, magnitudes, and statistical details are not provided in the abstract.

Key findings

  • In mice, the adjuvanted naked mRNA jet-injection vaccine exhibited lower local and systemic reactogenicity than LNP-formulated mRNA, as reported in the abstract.
“but with lower local and systemic reactogenicity”
What this piece can’t prove
  • Unclear whether reactogenicity assessments were blinded or standardized across groups.
  • Reactogenicity outcomes are reported alongside immunogenicity results but the abstract does not specify whether assessments were independent or derived from the same assays/samples.

2 further details could not be confirmed from the summary.

4in vivo animalDefine mechanistic requirements for the enhanced immunogenicity, implicating type I interferon and IL-6 signaling during immunization.in vivo mechanistic perturbation (abstract-level)Expand

In plain English

Abstract reports mechanistic investigations in mice showing that type I interferon and interleukin-6 signaling play key roles during immunization for the enhanced immunogenicity of an aluminum phosphate + CpG–adjuvanted naked mRNA vaccine delivered by jet injection. The pathways were implicated as required for the vaccine-driven increases in humoral (including IgG2a) and cellular immune responses.

Key findings

  • Type I interferon and interleukin-6 signaling were identified in mechanistic mouse studies as key requirements during immunization for the enhanced humoral (including IgG2a) and cellular immune responses induced by the aluminum phosphate + CpG–adjuvanted naked mRNA jet-injection vaccine.
“Mechanistic investigations revealed key roles for type I interferon ... signaling during immunization”
What this piece can’t prove
  • Causal interpretation (requirement of pathways) is implied but cannot be fully evaluated without the full methods and data.

2 further details could not be confirmed from the summary.

5in vivo animalDefine mechanistic requirements for the enhanced immunogenicity, implicating type I interferon and IL-6 signaling during immunization.Expand

In plain English

Abstract-reported mechanistic experiments in mice implicated interleukin-6 (IL-6) signaling as a key pathway during immunization with an aluminum phosphate + CpG–adjuvanted naked mRNA vaccine delivered by jet injection, associating IL-6 signaling with the vaccine's enhanced humoral and cellular immunogenicity.

Key findings

  • The paper's abstract reports that IL-6 signaling plays a key mechanistic role during immunization with an aluminum phosphate + CpG–adjuvanted naked mRNA vaccine delivered by jet injection in mice, contributing to the vaccine's enhanced humoral and cellular immune responses.
“Mechanistic investigations revealed key roles for ... interleukin-6 signaling during immunization”
What this piece can’t prove
  • All information for this unit is drawn from the paper abstract; experimental details of the mechanistic studies (methods, perturbation approach, timing, sample sizes, statistics) are not provided.

2 further details could not be confirmed from the summary.

6in vivo animalDemonstrate protective efficacy in vivo against respiratory viral infections (SARS-CoV-2 and influenza A H1N1) in mice, assessed by post-challenge virologic assays (plaque-forming assays).Mouse SARS-CoV-2 challenge protection studyExpand

In plain English

In mice, immunization with N1-methyl-pseudouridine–modified naked mRNA delivered by liquid jet-injection and adjuvanted with aluminum phosphate plus CpG oligodeoxynucleotide 'virtually eliminated' SARS-CoV-2 infection as measured by plaque-forming assays after viral challenge.

Key findings

  • Adjuvanted naked mRNA jet-injection vaccine (aluminum phosphate + CpG) virtually eliminated SARS-CoV-2 infection in challenged mice as measured by plaque-forming assays.Virtually eliminated infection (plaque-forming assay readout)
“virtually eliminated infection by ... SARS-CoV-2 ... in plaque-forming assays”
What this piece can’t prove
  • Summary is based solely on the abstract; quantitative data (PFU counts, group sizes, p-values), sampling timepoints, and anatomical sites for plaque assays are not provided.

1 further detail could not be confirmed from the summary.

7in vivo animalDemonstrate protective efficacy in vivo against respiratory viral infections (SARS-CoV-2 and influenza A H1N1) in mice, assessed by post-challenge virologic assays (plaque-forming assays).Mouse influenza challenge after immunization with adjuvanted naked mRNA (jet-injected)Expand

In plain English

In mice, jet-injected naked mRNA vaccines adjuvanted with aluminum phosphate + CpG were reported to 'virtually eliminate' detectable influenza A (A/California/7/2009 H1N1) infection as measured by plaque-forming assays after challenge.

Key findings

  • Adjuvanted naked mRNA jet-injection vaccine 'virtually eliminated infection' by influenza A (A/California/7/2009 H1N1) in mice as measured by plaque-forming assays.Qualitative: reported as 'virtually eliminated' detectable infectious virus (no numeric PFU values provided in abstract).
“virtually eliminated infection by ... influenza A virus (A/California/7/2009 H1N1) in plaque-forming assays”
What this piece can’t prove
  • Unclear whether outcome reflects absence of replicating virus in all animals or a strong reduction with some residual detection; phrase 'virtually eliminated' is qualitative.

2 further details could not be confirmed from the summary.

Finally, the search trail

Method layer

NewsLink found the paper. Tessa takes you deeper.

NewsLink checks the story. Tessa is where you inspect the paper, authors, evidence, and research context.

Papers considered

The selected paper, plus nearby candidates.

PubMed, Europe PMC, Crossref · 39 candidate papers

Candidate

N INVESTIGATION OF THE USAGE OF ENGLISH ARTICLES IN STUDENTS' ANDTEACHERS' SPOKEN DISCOURSE | Journal of Applied Linguistics and TESOL (JALT)

Scholarly Journal · 2026 · Crossref

Source (opens in a new tab)
Candidate

Author response for "Cu(I)-catalyzed, N-Fluorobenzamides Enabling 1,2-Carbofluorination of Unactivated Alkenes via Free Radical Relay"

2026 · Crossref

Source (opens in a new tab)

And 33 more candidates considered.